Covered recipient · General Payments record
KELLY RANDERMANN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$612.06
- Reported across 33 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $326.31 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $143.98 | 9 |
| DEXCOM, INC. | $68.91 | 3 |
| Regeneron Healthcare Solutions, Inc. | $28.42 | 1 |
| GlaxoSmithKline, LLC. | $23.90 | 1 |
| Amgen Inc. | $21.64 | 1 |
| BAXTER HEALTHCARE | $21.05 | 1 |
| Exact Sciences Corporation | $18.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.54 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108059543 | CMS |
| ABBVIE INC. | $11.12 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108059545 | CMS |
| ABBVIE INC. | $14.28 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108059547 | CMS |
| ABBVIE INC. | $12.07 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108059549 | CMS |
| ABBVIE INC. | $16.36 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108059551 | CMS |
| ABBVIE INC. | $19.87 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108059553 | CMS |
| ABBVIE INC. | $18.73 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108059555 | CMS |
| ABBVIE INC. | $16.27 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108059557 | CMS |
| ABBVIE INC. | $16.74 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108059559 | CMS |
| Amgen Inc. | $21.64 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117360654 | CMS |
| Baxter Healthcare | $21.05 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120668806 | CMS |
| Dexcom, Inc. | $24.28 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153371171 | CMS |
| Dexcom, Inc. | $23.54 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153371173 | CMS |
| Dexcom, Inc. | $21.09 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153371175 | CMS |
| Exact Sciences Corporation | $18.41 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114847346 | CMS |
| GlaxoSmithKline, LLC. | $23.90 | 12/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115887703 | CMS |
| Regeneron Healthcare Solutions, Inc. | $28.42 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114360442 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.